
OneSpan appears better positioned than Adyen on valuation and earnings outlook, with a Zacks Rank of #2 versus #3 for Adyen. OneSpan trades at a lower forward P/E of 11.51 versus 21.38 for Adyen, with a PEG of 1.05 and P/B of 1.93 compared with Adyen's 1.29 PEG and 5.63 P/B. The article concludes OneSpan is the superior value option, though the piece is primarily comparative commentary and is unlikely to materially move either stock.
The market is being told this is a simple relative-value call, but the more important signal is that OSPN’s multiple is already pricing in a far more fragile earnings path than the revision trend implies. When a small-cap software name screens this cheaply on forward earnings and book value while estimates are turning up, the setup is usually less about rerating to a premium and more about mean reversion in the sell-side’s terminal growth assumptions. That can create a fast, mechanically driven move because value screens and quant factors will often chase the same names once the revisions trend holds for another quarter.
Second-order, the real winner may be not OSPN’s product moat but its capital structure flexibility: a cheaper equity currency gives management more room to do tuck-in M&A, buybacks, or absorb transient margin pressure without the market immediately punishing them. By contrast, the richer multiple in ADYEY leaves much less room for disappointment if transaction volumes, take rates, or Europe/enterprise spend normalize; any deceleration would likely compress the stock disproportionately because investors are paying for durable compounding rather than cyclical recovery. In that sense, this is less a “who has the better business” call than a “whose expectations are more vulnerable” call.
The key risk to the long OSPN thesis is that estimate revisions are often lagging, not leading. If management commentary in the next 1-2 quarters shows that current-year upside is being pulled forward from lower-quality items like expense timing or one-off mix, the valuation gap can stay cheap or even widen. The contrarian read is that the market may be correctly distinguishing between a value trap and a quality compounder: OSPN may be optically cheap because its long-term growth ceiling is structurally lower, while ADYEY’s premium may be justified if its unit economics remain best-in-class.
From a trading standpoint, this looks better expressed as a relative-value pair than outright long-only beta. The most attractive setup is to own the cheaper name for 1-2 quarters into estimate revisions while shorting the richer multiple as a hedge against software factor drawdown. If the spread narrows meaningfully before the next earnings cycle, that is likely the cleanest moment to de-risk because the rerating will have already captured most of the easy upside.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment